血管内皮功能障碍和免疫血栓症在心房的发病过程中
Gabriel D Dungan1, Bulent Kantarcioglu2, Ameer Odeh1
1Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
概括
心房 (AF) 患者表现出高的内皮,炎症和血栓生物标志物. 这些标记物之间发现了显著的相关性,这表明AF病理生理学的复杂相互作用.
科学领域:
- 心血管医学 心血管医学
- 生物标志物研究 生物标志物研究
- 炎症和血栓形成的情况
背景情况:
- 心房 (AF) 与预炎症过程有关,导致血管内皮激活和功能障碍.
- 了解AF中各种生物标志物的相互作用对于识别疾病机制和潜在的治疗点至关重要.
研究的目的:
- 在心房患者中研究内皮,炎症,血栓和-血管酶系统 (RAS) 生物标志物之间的关系.
- 将AF患者的生物标志物水平与对照组进行比较.
主要方法:
- 预期在切除前招募110名AF患者,并采集100个控制血样本.
- 使用ELISA对内皮细胞 (例如NO,ICAM-1,VEGF),炎症 (例如IL-6,TNFα,CRP),血栓 (例如vWF,tPA,PAI-1) 和RAS (例如Renin,Ang-II) 生物标志物的分析.
- 统计分析包括生物标志物比较和斯皮尔曼相关性.
主要成果:
- 与对照组相比,AF患者的内皮,炎症和血栓生物标志物水平较高.
- 在几个生物标志物之间观察到显著的相关性,包括TNFα与IL-6,ICAM-1与TNFα,Annexin V与VEGF,CRP与VEGF,Ang-II与tPA,tPA与PAI-1.
- 在使用ACEI或ARB治疗的AF患者中,Angiotensin-II (Ang-II) 显著下降.
结论:
- 该研究证实了AF患者内皮质,炎症和血栓生物标志物的显著升高和相互关联.
- 需要进一步的研究来澄清内皮功能障碍和AF中血栓炎症的机制性途径.
- 识别这些途径可能会揭示新的治疗点,以补充抗凝剂并减少AF中的血栓性.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
01:16Clot Retraction and Fibrinolysis
4.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.0K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.5K
01:17Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
01:24Disorders of Hemostasis
707
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707